Human Induced Pluripotent Cell-Derived Sensory Neurons for Fate Commitment of Bone Marrow-Derived Schwann Cells: Implications for Remyelination Therapy

Sa Cai,Lei Han,Qiang Ao,Ying-Shing Chan,Daisy Kwok-Yan Shum
DOI: https://doi.org/10.5966/sctm.2015-0424
2016-01-01
Stem Cells Translational Medicine
Abstract:Strategies that exploit induced pluripotent stem cells (iPSCs) to derive neurons have relied on cocktails of cytokines and growth factors to bias cell-signaling events in the course of fate choice. These are often costly and inefficient, involving multiple steps. In this study, we took an alternative approach and selected 5 small-molecule inhibitors of key signaling pathways in an 8-day program to induce differentiationof human iPSCs into sensoryneurons, reaching‡80%yield in termsofmarkerproteins. Continuing culture in maintenance medium resulted in neuronal networks immunopositive for synaptic vesicle markers and vesicular glutamate transporters suggestive of excitatory neurotransmission. Subpopulations of the derived neurons were electrically excitable, showing tetrodotoxin-sensitive action potentials in patch-clamp experiments. Coculture of the derived neurons with rat Schwann cells under myelinating conditions resulted in upregulated levels of neuronal neuregulin 1 type III in conjunction with the phosphorylated receptors ErbB2 and ErbB3, consistent with amenability of the neuritic network to myelination. As surrogates of embryonic dorsal root ganglia neurons, the derived sensory neurons provided contact-dependent cues to commit bone marrow-derived Schwann cell-like cells to the Schwann cell fate. Our rapid and efficient induction protocol promises not only controlled differentiation of human iPSCs into sensoryneurons, but alsoutility in the translation to aprotocolwherebyhuman bonemarrow-derivedSchwanncellsbecomeavailable forautologous transplantationandremyelination therapy. STEM CELLS TRANSLATIONAL MEDICINE 2016;5:1–13
What problem does this paper attempt to address?